Amgen is a large biopharmaceutical company based in the U.S. capital region. It lobbies Congress mainly on Medicare and Medicaid rules, especially access and how doctors and patients are paid for drugs covered under Medicare Part B (drugs administered by doctors) and Part D (prescription drug plans), and on implementing parts of the 2022 Inflation Reduction Act. It disclosed four filings totaling $240,000 and used The McManus Group to help with lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN MCMANUS
The latest disclosures for this client.
THE MCMANUS GROUP
Q2THE MCMANUS GROUP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE MCMANUS GROUP
ALEX WHALEN
THE MCMANUS GROUP
ms LAWREN D GEER
THE MCMANUS GROUP
THE MCMANUS GROUP
Q4THE MCMANUS GROUP
Q3THE MCMANUS GROUP
Q2THE MCMANUS GROUP
Q1